Kura Oncology to Report First Quarter 2024 Financial Results - Kura Oncology (NASDAQ:KURA)

SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ:KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today

Related Keywords

Spain ,Alexandra Weingarten ,Linkedin ,Corporate Communications ,Kura Oncology Inc ,Vice President ,Investor Relations ,